University of Vermont

College of Medicine

Vermont Center for Immunobiology and Infectious Diseases

Bio for Beth Kirkpatrick, M.D.
Beth Kirkpatrick, M.D.

Beth Kirkpatrick, M.D.

Professor of Medicine, Infectious Disease Medicine
Department of Medicine


Contact Information
E-mail: Beth.Kirkpatrick@uvm.edu
Phone:
(802) 847-2264
Office Location:
University of Vermont Medical Center, 111 Colchester Ave., Smith 260, Burlington, Vermont 05401, USA

Education

1988-1992 M.D., Albany Medical College. Albany, New York
1992-1995 Intern and Resident, Internal Medicine, University of Rochester PCP - Stong Memorial Hospital, Rochester, New York
1994 Resident Physician, Kwai River Christian Hospital Sanglaburi, Thailand
1995-1996 Chief Resident and Clinical Instructor, Internal Medicine, University of Rochester Rochester General Hospital, Rochester, New York
1984-1988 B.S., Bates College, Lewiston, Maine
1992-1993 Internship, Internal Medicine, University of Rochester PCP - Strong Memorial Hospital, Rochester, New York
1996-1999 Fellowship, Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD
1997 The Gorgas Certification in Tropical Medicine and Travelers' Health.  Instituto de Medicina Tropical Alexander Von Homboldt

Research Interests

Vaccine Development, Human Immunology.

Academic Appointments

Professor of Medicine, University of Vermont Medical Center

Research Grants

2000 NIH-Allergy and Infectious Disease. R03 1R03 AI44279-01. Investigator. Pathogenesis of Human Cryptosporidiosis.
2000 Fletcher Allen Health Care. Patient Oriented Research Award. Principal Investigator. Streptococcal Virulence Factors.
2003 University of Vermont, New Research Initiative. “Disease Severity in Cryptosporidiosis: Association with Parasite genotype and Class II Human Leukocyte Antigens.”
2002 Microscience Ltd. A placebo-controlled, double-blind, single oral dose, dose-escalating study, to determine the immunogenicity and safety of three dose levels of freeze-dried MICRO-TY typhoid vaccine (oral live S. typhi (Ty2 aroC- ssaV-) ZH9) in healthy adult volunteers. Clinical contract. P.I.
1997-1999 Post-doctoral fellow. Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Disease. Mentor: Dr. Cynthia L. Sears, MD. Characterization of the human immune response to Cryptosporidium infection.
1998-1999 Post-doctoral fellow. Johns Hopkins School of Public Health, Department of International Health. Vaccine Testing Unit. Mentor: Dr. David Sack, M.D. Validation of a volunteer challenge model with Shigella sonnei.

Awards and Honors

1997 Infectious Disease Society of America, Fellow's Abstract Award
1997 Gorgas Institute Memorial Fellowship, The American Society of Tropical Medicine and Hygiene
1998 The Pearl M. Stetler Fund Research Fellowship, Johns Hopkins University School of Medicine
1999 The Pearl M. Stetler Fund Research Fellowship, Johns Hopkins University School of Medicine
2000 Fletcher Allen Health Care, Patient Orientated Research Award, Principal Investigator, Streptococcal Virulence Factors
2003 University of Vermont, New Research Initiative, "Disease Severity in Cryptosporidiosis: Association with Parasite genotype and Class II Human Leukocyte Antigens."
2006  University of Vermont Frymoyer Scholarship, "Global Health Education and Training for Health Care Professionals at UVM"
2010  Professor in Residence, Infectious Disease Institute, Makerere University, Kampala, Uganda
2012 University of Vermont, College of Medicine.  White Coat Ceremony. Key note speaker
2012  Bailey K. Ashford Medal. American Society of Tropical Medicine. Awarded for distinguished work in tropical medicine to a worker in his or her mid-career

Publications

Lindow JC, Fimlaid K, Bunn J, Kirkpatrick BD. Antibodies in Action :  The role of Human Opsonins in Killing Salmonella enterica serovar Typhi.  Infection and Immunity 2011; 79(8) 3188-3194

Anna Durbin,  Beth D. Kirkpatrick, Kristen K. Pierce, Alexander Schmidt, Stephen S. Whitehead. The Development and clinical evaluation of multiple monovalent DENV vaccines; identification of vaccines for inclusion in a live attenuated tetravalent VENV vaccine.  Vaccine 2011

Lindow JC, Poly F, Tribble DR, Guerry P, Carmolli MP, Baqar S, Porter CK, Pierce KK, Darsley MJ, Sadigh KS, Dill AE, Kirkpatrick BD. caught in the act: in vivo development of macrolide resistance to campylobacter jejuni infection. Journal of clinical Microbiology 2010; 48(8): 3012-3015

Grace C, Alston WK, Ramundo MB, Polish L, Kirkpatrick BD, Huston CD. The complexity , relative Value and Financial Workth of Curbside Consultations in an Academic Infectious Disease Unit. Clinical Infectious Diseases 2010; 51: 651-655

Dill E, Renault C, Kirkpatrick BK. "Trypanosoma brucei infection in a HIV-positive Ugandan male." Clinical and Laboratory Science 2011; 24(2): 85-88
Lindow JC, Fimlaid K, Bunn J, Durbin AP, Whitehead SS, Kirkpatrick BD. Primary vaccination with low dose live Dengue 1 virus Generates a pro-imflammatory, multifunctional T Cell response in humans. PLOS Neglected Tropical Diseases 2012; 6(7): e1742